SCHEDULE 13G/A: Patient Capital Management Discloses 6.53% Stake in Precigen, Inc. Common Stock

Patient Capital Management, LLC has filed an amended Schedule 13G, disclosing a beneficial ownership of 6.53% of Precigen, Inc.'s common stock as of December 31, 2024.

Summary

• Patient Capital Management, LLC reported beneficial ownership of 17,683,758 shares of Precigen, Inc. common stock.
• This ownership represents 6.53% of the total outstanding class of Precigen, Inc. common stock.
• The filing is an Amendment No. 2 to the Schedule 13G, with the event date requiring the filing being December 31, 2024.
• Patient Capital Management, LLC, organized in Delaware, holds sole voting power and sole dispositive power over all 17,683,758 shares.
• The reporting person is classified as an Investment Adviser (IA).
• The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of Precigen, Inc.

Sentiment

Score: 5

Explanation: The document is a factual disclosure of beneficial ownership and does not contain information that would inherently lead to a positive or negative sentiment. It is neutral in tone and content.

Positives

• A significant institutional investor, Patient Capital Management, LLC, holds a substantial stake (6.53%) in Precigen, Inc., which can be interpreted as a vote of confidence in the company's prospects.
• The investor explicitly states that the shares are held in the ordinary course of business and not for the purpose of changing or influencing control, suggesting a passive and potentially long-term investment strategy.

Management Comments

• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §§ 240.14a-11."

Industry Context

This filing is a standard disclosure of a significant ownership stake by an institutional investor, Patient Capital Management, LLC, in a publicly traded biotechnology company, Precigen, Inc. Such disclosures provide transparency regarding major shareholders but do not inherently reflect broader industry trends or competitive dynamics.

Stakeholder Impact

• Shareholders: Provides transparency regarding a significant institutional holder, which can influence market perception and liquidity.

Key Dates

Keywords

Precigen Inc., Patient Capital Management LLC, Schedule 13G, Common Stock, Beneficial Ownership, Institutional Investor, SEC Filing, Ownership Disclosure, Investment Adviser